Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins

Details for Australian Patent Application No. 2006315117 (hide)

Owner Revance Therapeutics, Inc.

Inventors Waugh, Jacob M.

Agent Freehills

Pub. Number AU-A-2006315117

PCT Pub. Number WO2007/059528

Priority 60/738,144 17.11.05 US

Filing date 16 November 2006

Wipo publication date 24 May 2007

International Classifications

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059528 Priority application(s): WO2007/059528

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315119-Antiperspirant compositions

2006315114-Mounting system for roofs and the like